TXMD [NASD]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-21.74 Insider Own0.10% Shs Outstand424.93M Perf Week0.61%
Market Cap86.85M Forward P/E- EPS next Y-2.26 Insider Trans0.00% Shs Float380.53M Perf Month0.20%
Income-182.10M PEG- EPS next Q-2.92 Inst Own29.60% Short Float0.53% Perf Quarter-47.58%
Sales86.40M P/S1.01 EPS this Y34.90% Inst Trans-12.06% Short Ratio1.76 Perf Half Y-45.97%
Book/sh-16.32 P/B- EPS next Y80.90% ROA-100.70% Target Price125.00 Perf Year-83.54%
Cash/sh3.49 P/C2.86 EPS next 5Y17.60% ROE213.80% 52W Range1.99 - 62.50 Perf YTD-43.97%
Dividend- P/FCF- EPS past 5Y1.10% ROI-147.60% 52W High-84.06% Beta1.96
Dividend %- Quick Ratio0.30 Sales past 5Y35.00% Gross Margin78.00% 52W Low400.50% ATR0.35
Employees416 Current Ratio0.30 Sales Q/Q-3.00% Oper. Margin- RSI (14)63.33 Volatility0.58% 1.40%
OptionableYes Debt/Eq- EPS Q/Q-0.30% Profit Margin- Rel Volume0.50 Prev Close9.95
ShortableYes LT Debt/Eq- EarningsMay 16 AMC Payout- Avg Volume1.14M Price9.96
Recom2.50 SMA200.31% SMA5025.36% SMA200-49.13% Volume569,813 Change0.10%
Aug-07-20Downgrade Jefferies Hold → Underperform
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Jun-06-22 04:05PM  
May-31-22 06:00AM  
May-20-22 10:52AM  
09:43AM  
May-16-22 08:00PM  
05:45PM  
04:05PM  
May-12-22 05:25PM  
May-10-22 04:05PM  
Apr-14-22 04:15PM  
Mar-10-22 01:30PM  
08:05AM  
06:50AM  
Mar-07-22 12:57PM  
07:40AM  
Mar-01-22 04:30PM  
Feb-28-22 05:35PM  
Feb-24-22 09:05AM  
Jan-25-22 08:52AM  
Jan-06-22 07:29AM  
Jan-04-22 06:20AM  
Dec-28-21 09:53AM  
Dec-13-21 06:08AM  
Dec-10-21 04:30PM  
Dec-08-21 06:50AM  
Nov-24-21 07:54AM  
Nov-22-21 10:40AM  
Nov-12-21 03:00AM  
Nov-11-21 06:50AM  
06:45AM  
Nov-04-21 03:01PM  
Oct-27-21 05:00PM  
Oct-15-21 05:33PM  
Oct-05-21 01:28PM  
Oct-04-21 09:20AM  
Sep-02-21 06:50AM  
Aug-23-21 06:50AM  
Aug-19-21 08:01AM  
Aug-09-21 04:30PM  
Aug-04-21 08:05AM  
06:50AM  
Jul-28-21 03:03PM  
Jul-26-21 06:50AM  
Jul-06-21 11:49AM  
Jun-29-21 08:58AM  
May-25-21 06:50AM  
May-24-21 07:00AM  
May-07-21 01:31AM  
May-06-21 10:56AM  
08:20AM  
07:00AM  
06:45AM  
May-03-21 07:00AM  
Apr-29-21 10:34AM  
07:00AM  
Apr-28-21 12:34PM  
Apr-09-21 11:16AM  
05:05AM  
Apr-08-21 04:05PM  
Mar-15-21 10:32AM  
Mar-02-21 07:00PM  
08:25AM  
07:22AM  
07:00AM  
06:30AM  
Mar-01-21 10:05AM  
07:00AM  
Feb-23-21 04:05PM  
Feb-18-21 10:16AM  
Feb-16-21 04:01PM  
12:02PM  
Feb-11-21 09:02AM  
Feb-10-21 04:01PM  
Feb-03-21 12:50PM  
Jan-29-21 03:29AM  
Jan-12-21 08:34AM  
Dec-29-20 07:00AM  
Dec-17-20 03:47AM  
Dec-15-20 08:13AM  
Dec-11-20 10:34AM  
Nov-13-20 04:05PM  
07:00AM  
Nov-11-20 12:29PM  
Nov-10-20 08:58AM  
Nov-09-20 04:01PM  
03:00PM  
08:15AM  
07:28AM  
06:55AM  
06:30AM  
Nov-02-20 12:31PM  
Oct-29-20 07:00AM  
Oct-28-20 12:33PM  
Oct-26-20 04:05PM  
10:01AM  
Oct-22-20 01:16PM  
Oct-09-20 08:00AM  
Oct-07-20 08:43AM  
Oct-06-20 10:03AM  
Oct-02-20 10:17AM  
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donegan Michael CCAO and VP of FinanceNov 30Sale0.5429,79015,94799,368Dec 02 06:30 AM
Collins Cooper C.DirectorNov 18Buy0.581,000,000578,5002,236,864Nov 22 06:30 AM
Collins Cooper C.DirectorAug 18Buy0.72900,000648,0001,236,864Aug 19 06:01 AM
Collins Cooper C.DirectorAug 17Buy0.77100,00077,000336,864Aug 19 06:01 AM
Ling KarenDirectorAug 17Buy0.7533,44525,084130,309Aug 19 04:31 PM
BISARO PAULDirectorAug 16Buy0.7950,00039,500196,864Aug 18 06:03 AM
Thompson Tommy GDirectorAug 13Buy0.8711,0009,570715,600Aug 17 06:47 AM
DArecca JamesChief Financial OfficerAug 12Sale0.8793,33781,203123,830Aug 12 09:33 PM